Bio-Connect
WB analysis of human placenta tissue lysate in (A) the absence and (B) the presence of blocking peptide using GTX85151 PLAC1 antibody. Working concentration : 1 microg/ml
WB analysis of human placenta tissue lysate in (A) the absence and (B) the presence of blocking peptide using GTX85151 PLAC1 antibody. Working concentration : 1 microg/ml
WB analysis of human placenta tissue lysate in (A) the absence and (B) the presence of blocking peptide using GTX85151 PLAC1 antibody. Working concentration : 1 microg/ml

PLAC1 antibody

GTX85151
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry
Product group Antibodies
ReactivityHuman
TargetPLAC1
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    PLAC1 antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1 microg/mL. ICC/IF: 10 microg/mL. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID10761
  • Target name
    PLAC1
  • Target description
    placenta enriched 1
  • Target synonyms
    cancer/testis antigen 92; CT92; OOSP2B; OOSP2L; placenta specific 1; placenta-specific protein 1
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDQ9HBJ0
  • Protein Name
    Placenta-specific protein 1
  • Scientific Description
    PLAC1 was initially identified as a protein expressed specifically in the placenta and other cells derived from the trophoblast lineage during embryonic development, but has also been found to be expressed ectopically in a wide range of human malignancies, particularly breast cancers. PLAC1 is a membrane-associated protein that is thought to serve a receptor-like function modulating cell-cell or ligand receptor interactions unique to the maternal-placental interface. Decreased expression of PLAC1 is associated with decreased expression of cyclin D1 and reduced expression of AKT kinase, which, combined with the fact that PLAC1 is expressed on the surface of cancer cells, suggests that PLAC1 may be an effective candidate for immunotherapeutic treatments of cancer.
  • Reactivity
    Human
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203